WDR76 and neoplasm: Immunohistochemical (IHC) analyses of these tissues revealed that RAS levels were higher in 41/46 (89.1%) HCC patient tumors compared with their adjacent non-tumor tissues, whereas WDR76 expression levels were lower in 34/46 (73.9%) of HCC tumors (Fig. 6a–c).